Newsfile Corp
26 Sept 2026, 01:27 UTC · 2h ago
Verdict
Headline takes no side. We score HIMS −0.80 across three claims — strongly bearish.
−0.80strongly bearish
More negative than 85% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish · 1 new · 2 priced in
Hims & Hers Health is facing a securities class action lawsuit alleging it shared consumer health data with third-party advertisers and charged for prescriptions before medical consultations.
Priced inmentions a lawsuit has already been filed
So whatProven regulatory violations regarding HIPAA or consumer protection could lead to multi-million dollar fines impacting net income in FY2027.
More negative than 85% of claims this week
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
The lawsuit claims Hims' conduct regarding data sharing and billing practices subjected the company to regulatory scrutiny and likely fees and penalties.
Priced inmentions a lawsuit has already been filed
So whatIncreased compliance costs and legal reserves would likely compress operating margins in the coming quarters.
More negative than 77% of claims this week
The deadline for investors who purchased HIMS securities between August 4, 2025, and July 29, 2026, to move to serve as lead plaintiff is November 2, 2026.
Newpress release dated September 25, 2026
More negative than 63% of claims this week
Which stocks this story touches
More negative than 85% of ticker scores this week
The company is facing a securities class action lawsuit alleging misleading statements regarding consumer privacy and billing practices.
More negative than 70% of ticker scores this week
The company is mentioned in the context of a securities class action deadline.
More negative than 70% of ticker scores this week
The company is mentioned in the context of a securities class action deadline.
More negative than 67% of ticker scores this week
The company is being targeted in a securities class action investigation.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
2h ago
—
HIMS hasn't traded since this ran. Last close $29.42 (Sep 25); the reaction starts at the next open.
HIMS chart →
